Stocks
Precipio, Inc.PRPO
NASDAQManufacturingDiagnostics & Research$20.01
Price as of · delayed, not real-time
A diagnostics company that develops and markets FDA-cleared tests for detecting hematological cancers, including a liquid biopsy platform for cancer monitoring. It also provides testing services to clinicians and partners with hospitals and laboratories. Investors track it for its niche in precision oncology diagnostics and its efforts to scale commercialization.
52W Range: $18.50-$33.63
Congressional Interest in Precipio, Inc. (PRPO)
No congressional trades have been disclosed for Precipio, Inc. (PRPO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PRPO?
No congressional trades found for this stock.